Nobody should be fooled into thinking that the drug industry’s rapid production of new COVID-19 vaccines will be based on altruism. To the contrary, it’s about making billions of dollars of shareholder profits.
Total global sales of these experimental vaccines are forecast to reach as high as $190 billion this year. Pfizer and Moderna are expected to dominate the market next year, between them generating over $93 billion. Along with other drug and vaccine makers, these companies will be seeking to ensure that COVID-19 continues to be a source of profits for many years to come.
Significantly, therefore, the goal of having new vaccines ready within 100 days was already agreed months before the discovery of the Omicron variant. At this year’s G7 meeting held in the UK, leaders of some of the world’s largest pharmaceutical exporting nations issued a declaration in which they committed to reducing the time taken to develop and license future COVID-19 vaccines to under 100 days. Claiming that current COVID-19 vaccines are ‘safe’ – despite being developed in under a year, being based on experimental gene technology, and only authorized via ‘emergency use’ mechanisms – the declaration pointedly ignores their lack of long-term safety data. Instead, the roles of the ‘private sector’ and ‘industry representatives’ are explicitly referred to and praised in the document. These terms are both code phrases for the multinational pharmaceutical investment industry, of course.
To read how Dr. Rath has issued an emergency call for the use of RNA- and DNA-based COVID-19 vaccines to be suspended due to their potentially devastating side effects, see this article on our website.
Chemotherapy May Affect Muscle Cells At Lower Doses Than Previously Thought
December 2, 2021Tuberculosis (The Forgotten Pandemic): How Vitamins Can Help End It
December 3, 2021New COVID-19 Vaccines ‘Ready In 100 Days’ If Omicron Variant Is Resistant To Current Ones, Pfizer Says
News
“Drug firms say they will be able to rapidly adapt their vaccinations if the Omicron variant spreads.” [Source: news.sky.com]
Comment
Nobody should be fooled into thinking that the drug industry’s rapid production of new COVID-19 vaccines will be based on altruism. To the contrary, it’s about making billions of dollars of shareholder profits.
Total global sales of these experimental vaccines are forecast to reach as high as $190 billion this year. Pfizer and Moderna are expected to dominate the market next year, between them generating over $93 billion. Along with other drug and vaccine makers, these companies will be seeking to ensure that COVID-19 continues to be a source of profits for many years to come.
Significantly, therefore, the goal of having new vaccines ready within 100 days was already agreed months before the discovery of the Omicron variant. At this year’s G7 meeting held in the UK, leaders of some of the world’s largest pharmaceutical exporting nations issued a declaration in which they committed to reducing the time taken to develop and license future COVID-19 vaccines to under 100 days. Claiming that current COVID-19 vaccines are ‘safe’ – despite being developed in under a year, being based on experimental gene technology, and only authorized via ‘emergency use’ mechanisms – the declaration pointedly ignores their lack of long-term safety data. Instead, the roles of the ‘private sector’ and ‘industry representatives’ are explicitly referred to and praised in the document. These terms are both code phrases for the multinational pharmaceutical investment industry, of course.
To read how Dr. Rath has issued an emergency call for the use of RNA- and DNA-based COVID-19 vaccines to be suspended due to their potentially devastating side effects, see this article on our website.
Dr. Rath Health Foundation
Related posts
People Who Take Paracetamol (Acetaminophen) Warned Even ‘Really Low’ Doses Can Damage Heart
Read more